ENTITY
CSL Ltd

CSL Ltd (CSL AU)

114
Analysis
Health CareAustralia
CSL Limited develops, manufactures and markets human pharmaceutical and diagnostic products derived from human plasma. The Company's products include pediatric and adult vaccines, infection, pain medicine, skin disorder remedies, antivenoms, anticoagulants, and immunoglobulins.
more
Refresh
20 Sep 2019 03:06

China Biologic's Privatisation Redux

On Wednesday after market close, China Biologic Products (CBPO US) announced a surprising privatisation bid from a consortium for $120 per ADS. The...

Logo
497 Views
Share
16 Sep 2019 17:44

Ramsay Health Care A$1.3bn Placement - A Decent Stock but Past Performance Weighs

Ramsay Health Care's largest shareholder, Paul Ramsay Foundation, is selling AUD 1.3 billion block after market close today. In this insight, we...

Logo
473 Views
Share
09 Sep 2019 08:22

Global Equity Strategy: Guarded Optimism

Global equities (MSCI ACWI) are decisively breaking above 1-month resistance on US-China trade war optimism, incrementally improving the technical...

Logo
387 Views
Share
05 Sep 2019 14:55

Australia Short Interest - August in Review

Of the 134 companies that reported annual results in August, 65% missed their targets on the top line and just over half reported a rise in profits...

Logo
454 Views
Share
29 Aug 2019 12:37

ASX Reporting Season Update: Misses and Downgrades Amongst Bright Spots

Reporting season has been relatively disappointing with only 45% of stocks able to either meet or beat FY19 expectations. Analyst expectations in...

Logo
553 Views
Share
x